Standex International Corporation SXI
280.17
0.57
0.20%
as of 25 Sep
- Market cap
- $3.4B
- P/E
- 32.2×
Follow SXI
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
41.11 | 30.97 | 48.39 | 48.27 |
+8 more quarters Free account |
P/S ratio |
4.83 | 3.47 | 3.01 | 3.04 | |
P/FCF ratio |
66.90 | 56.55 | 50.70 | 62.38 | |
P/Operating CF |
106.49 | 261.39 | 127.28 | 151.29 | |
P/B ratio |
5.70 | 4.07 | 3.74 | 3.60 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
5.21 | 3.88 | 3.52 | 3.57 | |
EV/EBITDA |
20.00 | 14.95 | 18.42 | 21.79 | |
EV/Operating CF |
51.86 | 41.67 | 38.02 | 43.45 | |
EV/FCF |
72.17 | 63.35 | 59.18 | 73.30 | |
Quick Ratio |
1.53 | 1.79 | 1.60 | 1.56 | |
Current Ratio |
2.40 | 3.05 | 2.87 | 2.87 | |
Net Debt/EBITDA |
7.22 | 3.68 | 9.61 | 11.30 | |
Debt/Assets |
32.66% | 30.97% | 34.40% | 35.03% | |
Debt/Equity |
0.69 | 0.63 | 0.76 | 0.77 | |
Asset Turnover |
0.57 | 0.57 | 0.57 | 0.65 | |
Operating CF/Net income |
1.97 | 0.18 | 9.70 | 1.12 | |
Capex/Depreciation |
(0.59) | (0.59) | (0.77) | (0.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.92% | 23.35% | 25.12% | 25.01% | |
Intangible Assets out of Total Assets |
0.49 | 0.52 | 0.52 | 0.53 | |
Share Based Compensation of Revenue |
0.98% | 0.77% | 1.38% | 0.82% | |
Graham Net Nets |
(0.06) | (0.09) | (0.14) | (0.14) | |
Graham Number |
110.82 | 107.66 | 76.64 | 76.28 | |
Earnings Yield |
2.43% | 3.23% | 2.07% | 2.07% | |
Free Cash Flow Yield |
1.49% | 1.77% | 1.97% | 1.60% | |
Revenue per Share |
18.96 | 18.64 | 18.38 | 18.10 | |
Operating CF per Share |
3.36 | 0.98 | 1.71 | 1.40 | |
Capex per Share |
(0.46) | (0.46) | (0.64) | (0.53) | |
Free Cash Flow per Share |
2.90 | 0.51 | 1.07 | 0.87 | |
Cash per Share |
14.85 | 8.61 | 8.05 | 8.21 | |
Shareholders Equity per Share |
62.74 | 62.60 | 58.14 | 58.91 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
62.74 | 62.60 | 58.14 | 58.91 | |
Free Cash Flow |
34.91 | 6.16 | 12.89 | 10.41 | |
Working Capital |
322.24 | 324.31 | 319.93 | 317.88 | |
Capital Expenditures |
(5.52) | (5.59) | (7.66) | (6.42) | |
Net Current Asset Value |
(278.74) | (289.88) | (363.53) | (359.63) | |
EV/EBIT |
23.99 | 18.03 | 24.20 | 30.19 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | |
Net Profit Margin |
8.97% | 29.82% | 0.96% | 6.92% | |
Price to Operating Income |
22.24 | 16.10 | 20.74 | 25.69 | |
| Other line items | |||||
Average Receivables |
172.80 | 174.79 | 164.90 | 142.68 | |
Average Payables |
84.05 | 76.92 | 80.58 | 77.10 | |
Average Inventory |
129.48 | 124.76 | 117.59 | 112.95 | |
Average Assets |
1,576.29 | 1,540.67 | 1,518.72 | 1,296.37 | |
Average Common Equity |
733.45 | 720.55 | 678.14 | 682.84 |
Columns are period end dates